| Title : The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia - Prades_2017_Eur.Neuropsychopharmacol_27_180 |
| Author(s) : Prades R , Munarriz-Cuezva E , Uriguen L , Gil-Pisa I , Gomez L , Mendieta L , Royo S , Giralt E , Tarrago T , Meana JJ |
| Ref : European Neuropsychopharmacology , 27 :180 , 2017 |
| Abstract : Prades_2017_Eur.Neuropsychopharmacol_27_180 |
| ESTHER : Prades_2017_Eur.Neuropsychopharmacol_27_180 |
| PubMedSearch : Prades_2017_Eur.Neuropsychopharmacol_27_180 |
| PubMedID: 27986355 |
Prades R, Munarriz-Cuezva E, Uriguen L, Gil-Pisa I, Gomez L, Mendieta L, Royo S, Giralt E, Tarrago T, Meana JJ (2017)
The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia
European Neuropsychopharmacology
27 :180
Prades R, Munarriz-Cuezva E, Uriguen L, Gil-Pisa I, Gomez L, Mendieta L, Royo S, Giralt E, Tarrago T, Meana JJ (2017)
European Neuropsychopharmacology
27 :180